Consumer Health

FDA Reauthorizes Philip Morris IQOS as Modified Risk Tobacco Product for Continued U.S. Marketing

FDA renews Philip Morris International's IQOS modified risk tobacco product authorization, allowing continued reduced-exposure claims for HEETS variants.